Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2,142.00
-6.50
(-0.30%)
As of 8:03:45 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 20 | 23 |
| Avg. Estimate | 5.47B | 6.13B | 25.69B | 31.31B |
| Low Estimate | 5.17B | 5.93B | 24.93B | 29.17B |
| High Estimate | 5.72B | 6.35B | 27B | 33.8B |
| Year Ago Sales | 4.33B | 5.07B | 20.78B | 25.69B |
| Sales Growth (year/est) | 26.13% | 20.80% | 23.67% | 21.86% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MLB1.F | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.50% | 10.82% | 14.15% |
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 2/21/2025 |
| Maintains | Susquehanna: Positive to Positive | 2/21/2025 |
| Maintains | B of A Securities: Buy to Buy | 2/21/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/21/2025 |
| Upgrade | Raymond James: Outperform to Strong Buy | 1/21/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 1/8/2025 |